PSTV icon

Plus Therapeutics
PSTV

Overview Fund Activity

28 hedge funds and large institutions have $1.58M invested in Plus Therapeutics in 2022 Q3 according to their latest regulatory filings, with 3 funds opening new positions, 4 increasing their positions, 7 reducing their positions, and 1 closing their positions.

Holders
28
Holders Change
+2
Holders Change %
+7.69%
% of All Funds
0.48%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
3
Increased
4
Reduced
7
Closed
1
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

1
Vanguard Group
1
Vanguard Group
Pennsylvania
$486K
2
TSS
2
Two Sigma Securities
New York
$29K
3
Susquehanna International Group
3
Susquehanna International Group
Pennsylvania
$21K
4
Citadel Advisors
4
Citadel Advisors
Florida
$7K
5
UBS Group
5
UBS Group
Switzerland
$7K

Top Sellers

1
PHP
1
Parkman Healthcare Partners
Connecticut
$590K
2
Morgan Stanley
2
Morgan Stanley
New York
$0
3
Renaissance Technologies
3
Renaissance Technologies
New York
$32K
4
WAM
4
Warberg Asset Management
Illinois
$5K
5
Millennium Management
5
Millennium Management
New York
$6K
Name Market Value Shares Shares
Change 		Shares
Change %
CFGS
26
Concourse Financial Group Securities
Alabama
– – – –
FP
27
Financial Perspectives
Minnesota
$0 1 – –
Barclays
28
Barclays
United Kingdom
$0 1 – –
Wells Fargo
29
Wells Fargo
California
$0 151 +1 +0.7%
UB
30
UMB Bank
Missouri
$0 54 +8 +17%
1
2